id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-287734-q7ae4dyf	Brosnahan, Shari B.	Thrombosis at Hospital Presentation in Patients with and without COVID-19	2020-11-10		.txt	text/plain	2073	125	48	In an observational study, patients 5 with severe COVID-19 and an elevated D-dimer or evidence of coagulopathy who received 6 thromboprophylaxis during hospitalization had decreased in-hospital mortality, 6 supporting 7 associations between thrombosis and outcomes. 7 Consequently, current society recommendations support chemical 9 thromboprophylaxis to mitigate thrombotic risk among inpatients with 8, 9 10 Catastrophic thrombotic events, including pulmonary embolism, stroke, and myocardial 11 infarction have been also reported in COVID-19 at the time of hospital presentation, suggesting 12 pre-hospital initiation of thrombus. In this study of patients with thrombosis before and after the COVID-19 pandemic, we observed 1 that the number of STEMI activations decreased, 18, 19 severe strokes in younger patients 2 increased, 20, 21 and incidence of deep vein thrombosis and pulmonary embolism increased, 22, 23 as 3 previously described in other cohorts. 17 We showed increased mortality in COVID-19 patients who develop outpatient thrombosis as Respiratory infections, and pneumonia specifically, have shown to increase incidence of venous 4 thromboembolism.	./cache/cord-287734-q7ae4dyf.txt	./txt/cord-287734-q7ae4dyf.txt